The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change.

Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.

Has your company won an Excellence Award?

Search to find out if your company is a winner

Search winners

What is Financing?

Financing recognises companies and institutions that have raised significant capital during the research period whether it be through corporate finance, the capital markets or fund raising.

This includes any significant raising of finance by a company within the sector, this can include corporate lending, funding rounds and equity and debt capital markets issues including share offers and bond issues. We will be specifically looking at high value deals; novel structures; and companies using (for them) new forms of financing such as high-yield bonds.


One of the dominant themes during this research period has been the funding of cancer drug and vaccine trials. Financial support for oncology related clinical trials has continued its upward trend with support from both private and public sources.

Another focus for the sector has been the funding of covid-related trials where both vaccines and drugs have received financial support.

Finally, the application of IT technologies in the field has continued at full speed and the funding of clinical trials platforms in general and trial decentralisation platforms in particular has been on the rise.

Is your company listed?

If you want to learn more about the Awards and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:

Contact: Olga Kovalova –

Book a meeting with Olga –


This category highlights clinical trial companies that have successfully attracted funding for their expansion plans.

This category highlights clinical trial start-ups that have successfully conducted investment rounds.